Chemical Structure
Cytostatin [457070-06-3]
AG-CN2-0093
Overview
- SupplierAdipoGen Life Sciences
- Product NameCytostatin
- Delivery Days Customer10
- CAS Number457070-06-3
- CertificationResearch Use Only
- Estimated Purity>75%
- Hazard InformationWarning
- Molecular FormulaC21H32NaO7P
- Molecular Weight450.4
- Scientific DescriptionChemical. CAS: 457070-06-3 - 682329-63-1 (free base). Formula: C21H32NaO7P. MW: 450.4. Isolated from Streptomyces sp. MJ654-NF4. Potent and selective protein phosphatase 2A (PP2A) inhibitor. Cell adhesion inhibitor. Inhibits the adhesion of B16 melanoma cells to laminin and collagen type IV in a dose dependent manner but not to fibronectin. Antitumor agent. Antimetastatic. Apoptosis inducer. - Potent and selective protein phosphatase 2A (PP2A) inhibitor [4-7]. Cell adhesion inhibitor [1]. Inhibits the adhesion of B16 melanoma cells to laminin and collagen type IV in a dose dependent manner but not to fibronectin [2]. Antitumor agent. Antimetastatic [2, 7]. Apoptosis inducer [3].
- SMILES[Na+].C\C=C\C=C/C=C\C(O)C(C)C(CCC(C)C1OC(=O)C=CC1C)OP(O)([O-])=O
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352200
References
- Cytostatin, a novel inhibitor of cell adhesion to components of extracellular matrix produced by Streptomyces sp. MJ654-NF4. I. Taxonomy, fermentation, isolation and biological activities: M. Amemiya, et al.; J. Antibiot. 47, 536 (1994)
- Inhibitory effect of cytostatin on spontaneous lung metastases of B16-BL6 melanoma cells: T. Masuda, et al.; J. Antibiot. 48, 528 (1995)
- Screening for apoptosis inducers in microbial products and induction of apoptosis by cytostatin: K. Yamazaki, et al.; J. Antibiot. 48, 1138 (1995)
- Cytostatin, an inhibitor of cell adhesion to extracellular matrix, selectively inhibits protein phosphatase 2A: M. Kawada, et al.; Biochim. Biophys. Acta 1452, 209 (1999)
- Small-molecule inhibitors of Ser/Thr protein phosphatases: specificity, use and common forms of abuse: M.R. Swingle, et al.; Methods Mol. Biol. 365, 23 (2007)
- Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and (beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors: M.R. Swingle, et al.; J. Pharmacol. Exp. Ther. 331, 45 (2009)
- Rubratoxin A specifically and potently inhibits protein phosphatase 2A and suppresses cancer metastasis: S. Wada, et al.; Cancer Sci. 101, 743 (2010)